Galangin inhibits cell invasion by suppressing the epithelial-mesenchymal transition and inducing apoptosis in renal cell carcinoma

Molecular Medicine Reports

Volumn 13, Issue 5, 2016, Pages 4238-4244

  Cao, Jingyi ^a,b   Wang, Hainan ^a   Chen, Feifei ^c   Fang, Jianzheng ^a   Xu, Aiming ^a   Xi, Wei ^a   Zhang, Shengli ^a   Wu, Gang ^b   Wang, Zengjun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Third People's Hospital   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Epithelial mesenchymal transition; Galangin; Invasion; Renal cell carcinoma

Indexed keywords

GALANGIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UVOMORULIN; VIMENTIN; FLAVONOID;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SPACE; KIDNEY CARCINOMA; METASTASIS INHIBITION; OXIDATIVE STRESS; PROTEIN EXPRESSION; RENAL CELL CARCINOMA CELL LINE; TUMOR INVASION; DRUG EFFECTS; KIDNEY TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FLAVONOIDS; HUMANS; KIDNEY NEOPLASMS; NEOPLASM INVASIVENESS; REACTIVE OXYGEN SPECIES;

EID: 84964771563     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5042     Document Type: Article

References (28)

1. Chow WH, Devesa SS, Warren JL and Fraumeni JF Jr: Rising incidence of renal cell cancer in the United States. JAMA 281:1628-1631, 1999.
2. Gupta K, Miller JD, Li JZ, Russell MW and Charbonneau C: Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review. Cancer Treat Rev 34:193-205, 2008.
3. Hollingsworth JM, Miller DC, Daignault S and Hollenbeck BK: Five-year survival after surgical treatment for kidney cancer: A population-based competing risk analysis. Cancer 109:1763-1768, 2007.
4. Hunt JD, Van Der Hel OL, McMillan GP, Boffetta P and Brennan P: Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies. Int J Cancer 114:101-108, 2005.
5. Yuan JM, Castelao JE, Gago-Dominguez M, Yu MC and Ross RK: Tobacco use in relation to renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 7:429-433, 1998.
6. Bjørge T and Tretli S and Engeland A: Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168-1176, 2004.
7. Van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA and Van Den Brandt PA: Relation of height, body mass, energy intake and physical activity to risk of renal cell carcinoma: Results from the Netherlands cohort study. Am J Epidemiol 160:1159-1167, 2004.
8. McLaughlin JK, Chow WH, Mandel JS, Mellemgaard A, McCredie M, Lindblad P, Schlehofer B, Pommer W, Niwa S and Adami HO: International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 63:216-221, 1995.
9. McCredie M, Pommer W, McLaughlin JK, Stewart JH, Lindblad P, Mandel JS, Mellemgaard A, Schlehofer B and Niwa S: International renal-cell cancer study. II. Analgesics. Int J Cancer 60:345-349, 1995.
10. McDermott DF: Immunotherapy of metastatic renal cell carcinoma. Cancer 115(Suppl 10):2298-2305, 2009.
11. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, et al: Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125-134, 2007.
12. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, et al: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115-124, 2007.
13. Zhang HT, Luo H, Wu J, Lan LB, Fan DH, Zhu KD, Chen XY, Wen M and Liu HM: Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway. World J Gastroenterol 16:3377-3384, 2010.
14. Capasso R and Mascolo N: Inhibitory effect of the plant flavonoid galangin on rat vas deferens in vitro. Life Sci 72:2993-3001, 2003.
15. Kim DA, Jeon YK and Nam MJ: Galangin induces apoptosis in gastric cancer cells via regulation of ubiquitin carboxy-terminal hydrolase isozyme L1 and glutathione S-transferase P. Food Chem Toxicol 50:684-688, 2012.
16. Zhang W, Tang B, Huang Q and Hua Z: Galangin inhibits tumor growth and metastasis of B16F10 melanoma. J Cell Biochem 114:152-161, 2013.
17. Heo MY, Sohn SJ and Au WW: Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat Res 488:135-150, 2001.
18. Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142, 2006.
19. Shi J, Wang DM, Wang CM, Hu Y, Liu AH, Zhang YL, Sun B and Song JG: Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition. Cancer Res 69:7180-7187, 2009.
20. Fan F, Samuel S, Evans KW, Lu J, Xia L, Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA and Ellis LM: Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med 1:5-16, 2012.
21. Saito RA, Watabe T, Horiguchi K, Kohyama T, Saitoh M, Nagase T and Miyazono K: Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res 69:2783-2791, 2009.
22. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428, 2009.
23. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890, 2009.
24. El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, Gandesiri M, Schneider-Stock R and Gali-Muhtasib H: Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 15:183-195, 2010.
25. Circu ML and Aw TY: Reactive oxygen species, cellular redox systems and apoptosis. Free Radic Biol Med 48:749-762, 2010.
26. Gamaley IA and Klyubin IV: Roles of reactive oxygen species: Signaling and regulation of cellular functions. Int Rev Cytol 188:203-255, 1999.
27. Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M, Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res 29:323-31, 2015.
28. Agati G, Azzarello E, Pollastri S, Tattini M, Flavonoids as antioxidants in plants: location and functional significance. Plant Sci. 2012 Nov; 196:67-76.